CCND1 and benign prostatic hyperplasia: In summary, the results of this study showed significantly higher expression of miR-106a-5p and miR-375-3p in prostate adenocarcinoma tissues compared with BPH, accompanied by lower expression of β-catenin, Fzd8, Wnt5a, and cyclin D1.